Current Atherosclerosis Reports·Oct 26Targeting Apolipoprotein C-III in Hypertriglyceridemia: Implications for Pancreatitis and Cardiovascular riskReviewAcute pancreatitisPaper
ESC Congress 2026 Abstract·Oct 26Apolipoprotein and inflammatory biomarker changes following marked triglyceride reduction with the GalNAc-conjugated APOC3 siRNA RBD5044Randomized trial in peopleInterventionsPaper
ESC Congress 2026 Abstract·Oct 26ION775, a long-acting siRNA targeting APOC3: single-dose, 12-month results in participants with moderate hypertriglyceridemiaRandomized trial in 40 peopleHypertriglyceridemiaPaper
ESC Congress 2026 Abstract·Oct 26Mechanisms underlying ApoC3-mediated PM2.5-Induced atherosclerotic cardiovascular diseaseExperiments in miceAPOC3Paper
Current Hypertension Reviews·Oct 20Cognitive Functions and Gene Polymorphism Associated with Cardiovascular Risk in Young Adults vs. Patients with Arterial HypertensionCross-sectional study of 152 peopleArterial hypertensionPaper
Nutrition Reviews·Oct 17Comparative Effects of Low-Fat and High-Fat Diets on Non-HDL Cholesterol, Apolipoproteins, and Lipoprotein Ratios: A Meta-Analysis of Randomized Controlled TrialsMeta-analysis of randomized trialsInterventionsPaper
European Journal of Pharmacology·Oct 13Effectiveness and Safety of Target-Specific RNA-Based Lipid-Lowering Therapies: A Systematic Review and Meta-Analysis of Randomized Controlled TrialsMeta-analysis of randomized trialsInterventionsPaper
Annual Review of Pharmacology and Toxicology·Oct 7Small Interfering RNA in Cardiovascular Disease: A New Frontier in Precision MedicineReviewCardiovascular diseasePaper
The Journal of Nutrition·Sep 22Dietary Patterns Are Key Predictors of Cardiovascular Risk Beyond Genetic Risk Across Metabolic Syndrome Trajectories in A Korean Prospective Cohort StudyCohort study of 58,701 peopleCardiovascular diseasePaper
GeroScience·Sep 10Apolipoprotein(a)-rich electronegative HDL accelerates vascular aging and atherosclerosis by inducing endothelial senescenceCohort study of 131 peopleCellular senescencePaper
Metabolism·Aug 24Discovery of functional variants regulating lipid metabolism in an East Asian populationGenetic association study of 72,298 peopleLipid and ceramide metabolismPaper
Clinical Epigenetics·Jul 17Aging-driven transcriptional programs in diabetic kidney disease: multi-omics discovery of diagnostic biomarkers and drug-repurposing targetsExperiments in ratsDiabetic kidney diseasePaper
Journal of Cardiovascular Pharmacology·Jun 26Silencing Triglycerides: The Clinical Impact of Plozasiran and apoC-III Inhibition in Severe HypertriglyceridemiaReviewInterventionsPaper
Circulation·Mar 30Effect of APOC3 Inhibition With Olezarsen on Coronary Atherosclerosis: Essence-TIMI 73b Imaging StudyRandomized trial in 468 peopleCoronary atherosclerosisPaper
medRxiv·Mar 11Triglyceride-rich lipoproteins, low-density lipoproteins, and risk of abdominal aortic aneurysmPreprint: Mendelian randomization in 383,983 peopleMechanismsPaper
EMBO Molecular Medicine·Dec 2Typhoid toxin of Salmonella Typhi elicits host antimicrobial response during acute typhoid feverStudy in peopleDNA damage responsePaper
Atherosclerosis·Mar 29Drug target Mendelian randomization supports apolipoprotein C3-lowering for lipoprotein-lipid levels reductions and cardiovascular diseases preventionMendelian randomization in 35,378 peopleMechanismsPaper
Aging·Mar 5FoxO6-mediated ApoC3 upregulation promotes hepatic steatosis and hyperlipidemia in aged rats fed a high-fat dietExperiments in ratsMechanismsPaper
Aging·Dec 21Causal effects of lipid-lowering therapies on aging-related outcomes and risk of cancers: a drug-target Mendelian randomization studyMendelian randomization in peoplePopulationsPaper
Journal of the American Heart Association·Dec 18Unraveling Potential Sex-Specific Effects of Cardiovascular Medications on Longevity Using Mendelian RandomizationMendelian randomization in 415,311 peopleInterventionsPaper
Lipids in Health and Disease·Dec 12Genetic insights into the association of statin and newer nonstatin drug target genes with human longevity: a Mendelian randomization analysisMendelian randomization in 500,193 peoplePopulationsPaper
Biomedicines·Apr 24Apolipoprotein C3-Rich Low-Density Lipoprotein Induces Endothelial Cell Senescence via FBXO31 and Its Inhibition by Sesamol In Vitro and In VivoExperiments in animalsInterventionsPaper
JAMA Network Open·Jul 11Association of Apolipoprotein E in Lipoprotein Subspecies With Risk of DementiaStudy in peopleBiomarkersPaper
EBioMedicine·Jul 14Genetically-predicted life-long lowering of low-density lipoprotein cholesterol is associated with decreased frailty: A Mendelian randomization study in UK biobankMendelian randomization in 378,161 peoplePopulationsPaper
Journal of Proteome Research·Mar 21Proteomic Analysis of Human Plasma during Intermittent FastingTrial in peopleInterventionsPaper
Neurobiology of Aging·Apr 19Plasma apolipoproteins and physical and cognitive health in very old individualsCohort study of 1,067 peopleBiomarkersPaper
Experimental Gerontology·Mar 8No Association between Variation in Longevity Candidate Genes and Aging-related Phenotypes in Oldest-old DanesGenetic association study of 1,281 peopleMechanismsPaper
Nutrition·Feb 10Nutritional habits, lifestyle, and genetic predisposition in cardiovascular and metabolic traits in Turkish populationCross-sectional study in peoplePopulationsPaper